OncoGenex Pharmaceuticals (NASDAQ:OGXI) has signed an agreement with Teva to regain rights to custirsen, now in phase 3 development. Custirsen blocks production of the protein clusterin, which may play a role in cell survival and treatment resistance in patients with prostate and lung cancers. By inhibiting clusterin, the drug could slow tumor growth to allow therapies to be more effective. Data from the AFFINITY and ENSPIRIT trials are expected late this year or early 2016. On Friday shares of OncoGenex Pharmaceuticals, Inc. (NASDAQ:OGXI) closed at $2.45.
Aemetis, Inc. (NASDAQ: AMTX) announced that the company will host an earnings review and business update call following the release of its fourth quarter/2014 year-end earnings report on Thursday, March 12, 2015 at 1:15 pm Pacific Time (PT). Aemetis, Inc. (NASDAQ:AMTX) in last trading activity increased 4.04% to close at $4.96. Company weekly performance is 12.27% while its quarterly performance stands at 8.12%. Aemetis, Inc. (NASDAQ:AMTX) is -62.66% away from its 52 week high.
Facebook Inc (NASDAQ:FB) is modifying the way it keeps track of likes on pages, which belong to a variety of businesses and numerous celebrities as well. On Friday shares of Facebook Inc (NASDAQ:FB) closed at $80.00. Company’s sales growth for last 5 years was 74.20% and EPS growth for next 5 years is recorded as 31.46%.
Liberty Tax, Inc. (NASDAQ: TAX) (the “Company”) reported its results for the third fiscal quarter ended January 31, 2015. Revenues for the three months ended January 31, 2015 increased 17% to $47.7 million compared to $40.7 million in the prior year period. Liberty Tax, Inc. (NASDAQ:TAX) has 30.30% insider ownership while its institutional ownership stands at 44.90%. In last trading activity company’s stock closed at $29.26.
On 3 March 2015, Roche Holding Ltd. (ADR) (OTCMKTS:RHHBY) has announced to extend the final expiration date of its tender for Foundation Medicine Inc (NASDAQ:FMI). According to reports, the updated tender offer allows the company to buy up to 15.6 million of the outstanding common shares of FMI at a pre-decided cash price of $50 per share. RHHBY can now buy all the shares of FMI until midnight of April 6, 2015. On last trading day Foundation Medicine, Inc. (NASDAQ:FMI) increased 1.15% to close at $47.51. Its volatility for the week is 1.59% while volatility for the month is 1.61%. Foundation Medicine, Inc. (NASDAQ:FMI) monthly performance is -0.94%.